The socioeconomic burden of SLE

Nature Reviews Rheumatology

Volumn 5, Issue 7, 2009, Pages 400-404

  Lau, Chak Sing ^a   Mak, Anselm ^b  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

COST OF ILLNESS; DISABLED PERSON; ECONOMICS; FEMALE; HEALTH CARE COST; HUMAN; PATHOPHYSIOLOGY; QUALITY OF LIFE; REVIEW; SOCIOECONOMICS; STATISTICS; SYSTEMIC LUPUS ERYTHEMATOSUS;

COST OF ILLNESS; DISABLED PERSONS; FEMALE; HEALTH EXPENDITURES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; QUALITY OF LIFE; SOCIOECONOMIC FACTORS;

EID: 70349561258     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2009.106     Document Type: Article

References (52)

1. Petri, M. Epidemiology of systemic lupus erythematosus. Best Pract. Res. Clin. Rheumatol. 16, 847-858 (2002).
2. Tikly, M. & Navarra, S. V. Lupus in the developing world—is it any different? Best Pract. Res. Clin. Rheumatol. 22, 643-655 (2008).
3. Trager, J. & Ward, M. M. Mortality and causes of death in systemic lupus erythematosus. Curr. Opin. Rheumatol. 13, 345-351 (2001).
4. Rahman, P, Gladman, D. D., Urowitz, M. B., Hallett, D. & Tam, L. S. Early damage as measured by the sLICC/ACR damage index is a predictor of mortality in systemic lupus erythematosus. Lupus 10, 93-96 (2001).
5. Mok, C. C., Mak, A., Chu, W. P, To, C. H. & Wong, S. N. Long-term survival of southern Chinese patients with systemic lupus erythematosus: a prospective study of all age- groups. Medicine (Baltimore) 84, 218-224 (2005).
6. Manzi, S. et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham study. Am. J. Epidemiol. 145, 408-415 (1997).
7. Bjornadal, L., Yin, L., Granath, F., Klareskog, L. & Ekbom, A. Cardiovascular disease a hazard despite improved prognosis in patients with systemic lupus erythematosus: results from a swedish population-based study 1964-95. J. Rheumatol. 31, 713-719 (2004).
8. Nossent, J. et al. Current causes of death in systemic lupus erythematosus in Europe, 2000-2004: relation to disease activity and damage accrual. Lupus 16, 309-317 (2007).
9. Urowitz, M. B., Gladman, D. D., Tom, B. D., Ibanez, D. & Farewell, V. T. Changing patterns in mortality and disease outcomes for patients with systemic lupus erythematosus. J. Rheumatol. 35, 2152-2158 (2008).
10. Cardoso, C. R., signorelli, F. V., Papi, J. A. & salles, G. F. Initial and accrued damage as predictors of mortality in Brazilian patients with systemic lupus erythematosus: a cohort study. Lupus 17, 1042-1048 (2008).
11. Danila, M. I. et al. Renal damage is the most important predictor of mortality within the damage index: data from the LUMINA LXIV, a multiethnic Us cohort. Rheumatology (Oxford) 48, 542-545 (2009).
12. Mok, C. C., To, C. H. & Mak, A. Neuropsychiatric damage in southern Chinese patients with systemic lupus erythematosus. Medicine (Baltimore) 85, 221-228 (2006).
13. Ramsey-Goldman, R. Frequency of fractures in women with systemic lupus erythematosus: comparison with United states population data. Arthritis Rheum. 42, 882-890 (1999).
14. Bultink, I. E., Lems, W. F., Kostense, P J., Dijkmans, B. A. & Voskuyl, A. E. Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus. Arthritis Rheum. 52, 2044-2050 (2005).
15. Yee, C. S. et al. Prevalence and predictors of fragility fractures in systemic lupus erythematosus. Ann. Rheum. Dis. 64, 111-113 (2005).
16. Mak, A., Mok, C. C. & To, C. H. Incidence and risk factors of fragility fractures in southern Chinese patients with systemic lupus erythematosus. Ann. Rheum. Dis. 65 (Suppl.), s423 (2006).
17. Lau C. S., Yin, G. & Mok, M. Y. Ethnic and geographical differences in systemic lupus erythematosus: an overview. Lupus 15, 715-719 (2006).
18. Clarke, A. E. et al. Underestimating the value of women: assessing the indirect costs of women with systemic lupus erythematosus. Tri-Nation study Group. J. Rheumatol. 27, 2597-2604 (2000).
19. Utset, T. O., Fink, J. & Doninger, N. A. Prevalence of neurocognitive dysfunction and other clinical manifestations in disabled patients with systemic lupus erythematosus. J. Rheumatol. 33, 531-538 (2006).
20. Bertoli, A. M., Fernandez, M., Alarcon, G. S., Vila, L. M. & Reveille, J. D. systemic lupus erythematosus in a multiethnic Us cohort LUMINA (XLI): factors predictive of self-reported work disability. Ann. Rheum. Dis. 66, 12-17 (2007).
21. Mok, C. C., Cheung, M. Y, Ho, L. Y, Yu, K. L. & To, C. H. Risk and predictors of work disability in Chinese patients with systemic lupus erythematosus. Lupus 17, 1103-1107 (2008).
22. Tam, L. s. et al. The relationship between neuropsychiatric, clinical, and laboratory variables and quality of life of Chinese patients with systemic lupus erythematosus. J. Rheumatol. 35, 1038-1045 (2008).
23. Clarke, A. E. et al. An international perspective on the well being and health care costs for patients with systemic lupus erythematosus. Tri-Nation study Group. J. Rheumatol. 26, 1500-1511 (1999).
24. Clarke, A. E. et al. The systemic lupus erythematosus Tri-Nation study: absence of a link between health resource use and health outcome. Rheumatology (Oxford) 43, 1016-1024 (2004).
25. Clarke, A. E. et al. A Canadian study of the total medical costs for patients with systemic lupus erythematosus and the predictors of costs. Arthritis Rheum. 36, 1548-1559 (1993).
26. sutcliffe, N., Clarke, A. E., Taylor, R., Frost, C. & Isenberg, D. A. Total costs and predictors of costs in patients with systemic lupus erythematosus. Rheumatology (Oxford) 40, 37-47 (2001).
27. Huscher, D. et al. Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany. Ann. Rheum. Dis. 65, 1175-1183 (2006).
28. Panopalis, P. et al. Health care costs and costs associated with changes in work productivity among persons with systemic lupus erythematosus. Arthritis Rheum. 59, 1788-1795 (2008).
29. Clarke, A. E. et al. SLE patients with renal damage incur higher health care costs. Rheumatology (Oxford) 47, 329-333 (2008).
30. Panopalis, P. et al. The systemic lupus erythematosus Tri-Nation study: cumulative indirect costs. Arthritis Rheum. 57, 64-70 (2007).
31. Hanly, J. G. Disease activity, cumulative damage and quality of life in systemic lupus erythematosus: results of a cross sectional study. Lupus 6, 243-247 (1997).
32. Abu-shakra, M. et al. Quality of life in systemic lupus erythematosus: a controlled study. J. Rheumatol. 26, 306-309 (1999).
33. Thumboo, J. et al. Validation of the MOs sF-36 for quality of life assessment of patients with systemic lupus erythematosus patients in singapore. J. Rheumatol. 26, 97-102 (1999).
34. Thumboo, J. et al. Validation of the Chinese sF-36 for quality of life assessment in patients with systemic lupus erythematosus. Lupus 9, 708-712 (2000).
35. Thumboo, J. et al. A prospective study of factors affecting quality of life in systemic lupus erythematosus. J. Rheumatol. 27, 1414-1420 (2000).
36. Wang, C., Mayo N. E. & Fortin, P. R. The relationship between health related quality of life and disease activity and damage in systemic lupus erythematosus. J. Rheumatol. 28, 525-532 (2001).
37. strand, V. et al. Baseline data from 5 randomized controlled trials (RCTs) demonstrate that systemic lupus erythematosus (sLE) impacts all domains of health related quality of life (HRQoL). Arthritis Rheum. 54, s277 (2006).
38. Panopalis, P et al. The systemic lupus erythematosus Tri-Nation study: longitudinal changes in physical and mental well-being. Rheumatology (Oxford) 44, 751-755 (2005).
39. Ware, J. E. Jr & sherbourne, C. D. The MOs 36- item short form health survey (sF-36). Conceptual framework and item selection. Med. Care 30, 473-483 (1992).
40. Jolly, M. How does quality of life of patients with systemic lupus erythematosus compare with that of other common chronic illness? J. Rheumatol. 32, 1706-1708 (2005).
41. Panopalis, P. & Clarke, A. E. Quality of life in systemic lupus erythematosus. Clin. Dev. Immunol. 13, 321-324 (2006).
42. McElhone, K., Abbott, J. & The, L. S. A review of health related quality of life in systemic lupus erythematosus. Lupus 15, 633-643 (2006).
43. Bultink, I. E., Turkstra, F., Dijkmans, B. A. & Voskuyl, A. E. High prevalence of unemployment in patients with systemic lupus erythematosus: association with organ damage and health- related quality of life. J. Rheumatol. 35, 1053-1057 (2008).
44. Vu, T. V. & Escalante, A. A comparison of the quality of life of patients with systemic lupus erythematosus with and without endstage renal disease. J. Rheumatol. 26, 2595-2601 (1999).
45. Boehncke, W. H., Ochsendorf, F., Paeslack, I., Kaufmann, R. & Zollner, T. M. Decorative cosmetics improve the quality of life in patients with disfiguring skin diseases. Eur. J. Dermatol. 12, 577-580 (2002).
46. Fortin, P R. et al. Impact of disease activity and cumulative damage on the health of lupus patients. Lupus 7, 101-107 (1998).
47. Tse, K. C., Tang, C. S., Lio, W. I., Lam, M. F. & Chan, T. M. Quality of life comparison between corticosteroid-and-mycophenolate mofetil and corticosteroid-and-oral cyclophosphamide in the treatment of severe lupus nephritis. Lupus 15, 371-379 (2006).
48. Mok, C. C., Ho, L. Y, Cheung, M. Y, Yu, K. L. & To, C. H. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study. Scand. J. Rheumatol. 5, 1-7 (2008).
49. Leong, K. P et al. Development and preliminary validation of a systemic lupus erythematosus- specific quality-of-life instrument (sLEQOL). Rheumatology (Oxford) 44, 1267-1276 (2005).
50. McElhone, K. et al. Development and validation of a disease-specific health-related quality of life measure, the LupusQol, for adults with systemic lupus erythematosus. Arthritis Rheum. 57, 972-979 (2007).
51. Dorward, L. C. et al. The development of the L-QoL: a quality-of-life instrument specific to systemic lupus erythematosus. Ann. Rheum. Dis. 68, 196-200 (2009).
52. Thumboo, J. & Wee, H. L. Systemic lupus erythematosus in Asia: is it more common and more severe? J. Rheumatol. 9, 320-326 (2006).